Cerner collecting Gaucher disease data in new registry

Cerner launched a registry that will collect data from patients diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disease. Cerner and the International Gaucher Alliance, announced the opening of the Gardian  (Gaucher Registry for Development Innovation and Analysis of Neuronopathic Disease) registry. It will collect retrospective and prospective clinical and health outcome data for patients diagnosed with Gaucher disease, according to an April 26 press release.   The registry is owned by the patient community, but will be led by Cerner Enviza, an EHR data set.